Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Patient Return Electrodes Market size was over USD 208.21 million in 2024 and is anticipated to cross USD 539.59 million by 2037, growing at more than 7.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of patient return electrodes is assessed at USD 234.3 million.
The major factor attributed to the expansion of the market is the rising utilization rate of electrosurgical devices during surgical procedures to improve the outcome, enhance the process, and better the patient’s experience. From recent calculations, it was revealed that more than 80% of surgeries performed today across the world involve devices that apply energy to tissues.
Electrosurgery is generally used to treat benign tumors, warts, and other non-cancerous growths. Hence, the rising adoption of electrosurgery and bipolar electrosurgical devices is estimated to boost the market growth during the analysis period. Moreover, the rapid advancement in health technology, backed by growing investment in R&D activities, is estimated to boost the market growth. In addition to the aforementioned factors, the rapid adoption of an unhealthy lifestyle and poor diets has propelled the growth of numerous diseases which has caused the number of surgeries to increase and generate the demand for patient return electrodes. Also, the rising focus on developing safe surgical devices coupled with the escalation in preference for minimally invasive surgeries and the rapid surge in ambulatory surgery devices are considered to be other factors that are anticipated to bring in lucrative growth opportunities for the global patient return electrodes market growth. Furthermore, the expansion of a large pool of patient present in the world and the growth in the number of non-communicable diseases which requires various surgeries is projected to increase the utilization rate of patient return electrodes in the upcoming years.
Patient Return Electrodes Sector: Growth Drivers and Challenges
Growth Drivers
-
Rising Geriatric People Across the Globe – Recently, the world has seen a boom in the number of elderly people which has resulted in considerable growth in the prevalence of various diseases among them owing to their weak bodies and deteriorating body organs. Thus, the increasing number of elderly people undergoing surgical procedures for treatment processes is considered to generate a higher demand for patient return electrodes in the next few years. As of the end of 2021, there were 747,238,580 elderly people in the world, according to the data reported by the World Bank. In the future, the number is expected to increase to reach 1 elderly individual in every 6 people by 2030.
-
Growing Need for Patient Return Electrodes During Surgical Procedures – With the growing cases of various diseases among the global population, the number of surgeries being performed worldwide has also subsequently increased, bringing in favorable opportunities for market expansion during the forecast period. As per a recently published by the National Library of Medicine, National Center for Biotechnology Information in 2020, it was calculated that around 310 million major surgeries are performed every year across the globe, with approximately 40 to 50 million being performed in the United States and 20 million in Europe.
-
Surge in Non-Communicable Diseases – As the global population is engaged in unhealthy lifestyles, the rate of diseases among people has considerably grown up which is increasing the demand for patient return electrodes for the conduction of effective surgery. The World Health Organization (WHO) stated that non-communicable diseases kill almost 41 million people worldwide every year, which is equivalent to 74% of total global deaths.
-
Escalation in Disposable Income of People – As the economies are growing, the personal disposable income of people is also increasing with rising spending capacity for health and fitness. Thus, the increased spending capacity indicates the rising preference for opting for patient return electrodes and aiding in market expansion in the assessment period. According to the Bureau of Economic Analysis, the amount of personal income and disposable personal income (DPI) in the world increased to reach USD 47 billion (0.2%) and USD 37.6 billion (0.2%), respectively, during the July 2022.
-
Increase in Number of Cardiac Surgeries – Along with the rise in cardiovascular diseases, the number of cardiac surgeries being performed annually has also increased. This trend is anticipated to create a positive outlook for the expansion of market size. For instance, a report from 2022 suggested that the number of open-heart surgeries being performed on more than 2 million people worldwide.
Challenges
- High Cost of Electro Surgery – As patient return electrodes are highly advanced medical equipment, their cost is also high owing to the integration of the latest features and high-technology components. Thus, the cost of electrosurgeries is also estimated to rise. However, this trend is expected to lower the adoption rate of patient return electrodes among the population with low to middle income.
- Less Awareness Level of Benefits among the Population
- Rising Risks Associated with the Procedures
Patient Return Electrodes Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.6% |
|
Base Year Market Size (2024) |
USD 208.21 million |
|
Forecast Year Market Size (2037) |
USD 539.59 million |
|
Regional Scope |
|
Patient Return Electrodes Segmentation
End-user (Hospitals, Ambulatory Surgical Centers, Research Laboratories, Academic Institutes)
The global patient return electrodes market is segmented and analyzed for demand and supply by end-user in hospitals, ambulatory surgical centers, research laboratories, academic institutions, and others. Out of these, the hospitals segment is attributed to holding the largest segment in the market during the forecast period. The major factor for segment growth is the presence of a large number of hospitals across the world and rising investments by the governments of different nations and major key players to enhance hospital settings. For instance, the Organization for Economic Co-Operation and Development (OECD) stated that the number of hospitals in the United Kingdom increased from 1,882 in 2015 to 1921 in 2020, whereas, in the United States it rose from 5,564 in 2015 to 6,090 in 2019. Furthermore, the high number of patients visiting hospitals daily along with the presence of facilities in hospital settings are other factors that are expected to bring in favorable opportunities for segment expansion.
Surgery Type (General Surgery, Gynecology Surgery, Cardiovascular Surgery, Neurosurgery)
The global patient return electrodes market is also segmented and analyzed for demand and supply by surgery type into general surgery, gynecology surgery, cardiovascular surgery, neurosurgery, and others. Out of these, the general surgery segment is projected to garner a noteworthy share with a notable revenue generation by the end of 2037, owing to the high number of general surgeries being performed across the world as a result of a high number of diseases being diagnosed every day. For instance, it is estimated that around 11% of the global burden of disease requires surgical care and anesthesia devices. Also, the rising prevalence of numerous diseases in the world is another factor for segment growth.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Patient Type |
|
|
By Surgery Type |
|
|
By End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Patient Return Electrodes Industry - Regional Synopsis
North American Market Forecast
North America industry is expected to dominate majority revenue share by 2037, attributed to increasing frequency of chronic diseases and acute disorders amongst several people, driven by sedentary lifestyle of individuals. The growth of the market can be attributed majorly to the increasing frequency of chronic diseases and acute disorders amongst several people, backed by the sedentary lifestyle of individuals. The data released by the Centers for Disease Control and Prevention (CDC), it is estimated that six out of ten Americans live with at least one chronic disease such as heart disease, heart stroke, cancer, and diabetes. Further, the presence of a strong healthcare network in the region, along with the availability of a large pool of patients to develop efficient treatment options, are also anticipated to contribute to market growth in the region. In addition, the region's expanding healthcare industry and rising healthcare expenditure are also anticipated to boost market growth during the forecast period.
APAC Market Statistics
On the other hand, the Asia Pacific patient return electrode market is also anticipated to hold a noteworthy share during the analysis period. The rising geriatric population along with the prevalence of various types of diseases among the population is estimated to create a positive outlook for revenue generation for market growth. Also, the favorable conditions reinforced by the governments and the presence of key players are estimated to increase the utilization rate of patient-run electrodes during the next few years.
Companies Dominating the Patient Return Electrodes Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Medtronic Plc
- Boston Scientific Corporation
- Stryker Corporation
- Olympus Corporation
- Conmed Corporation
- Utah Medical Products, Inc.,
- KLS Martin GmbH & Co. KG
- Arthrex GmbH
- AtriCure Inc.
Recent Developments
-
Stryker announced the acquisition of Vocera Communications, Inc., a leader in digital care coordination and communication. The acquisition provides significant opportunities to advance innovations and accelerate our digital aspirations.
-
Karl Leibinger Medizintechnik GmbH & Co. KG, part of the KLS Martin Group, inaugurated a new implant production building.
Author Credits: Radhika Pawar
- Report ID: 4028
- Published Date: Dec 20, 2024
- Report Format: PDF, PPT
